Tianyin Pharmaceutical (TPI) Q2 EPS Drops to $0.06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq slides to near one-month low as AI rout deepens
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts TPI Hot Sheet
Join SI Premium – FREE
Tianyin Pharmaceutical (NYSE: TPI) reported Q2 EPS of $0.06, versus $0.20 reported last year. Revenue for the quarter came in at $18.2 million, versus $25.3 million reported last year.
For earnings history and earnings-related data on Tianyin Pharmaceutical (TPI) click here.
For earnings history and earnings-related data on Tianyin Pharmaceutical (TPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FMC tumbles 35% after slashing Q3 outlook over weak demand and inventory issues
- State Street (STT) PT Lowered to $175 at RBC Capital
- Kimberly-Clark shares rise following preliminary Q3 earnings beat
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
